Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary pain
Clinical narrative: Significant amount of lymph nodes calcified with one becoming infected and enlarged near my heart and still causing pain and discomfort; Significant amount of lymph nodes calcified with one becoming infected and enlarged near my heart and still causing pain and discomfort; Significant amount of lymph nodes calcified with one becoming infected and enlarged near my heart and still causing pain and discomfort; Significant amount of lymph nodes calcified with one becoming infected and enlarged near my heart and still causing pain and discomfort; Significant amount of lymph nodes calcified with one becoming infected and enlarged near my heart and still causing pain and discomfort / discomfort in xyphoid process area; Abnormal pains in chest from lungs; Abnormal pains in chest from lungs; Pain in xyphoid process area; Significantly and frequently exhausted with testosterone loss; Significantly and frequently exhausted with testosterone loss; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old male patient received BNT162b2 (BNT162B2), on 15Oct2021 as dose 3 (booster), single (Lot number: FD0809) at the age of 33 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "COVID-19" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Morphine, reaction(s): "Known allergies". Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EL9262, Location of injection: Arm Left), administration date: 21Jan2021, when the patient was 32-year-old, for COVID-19 immunization; BNT162b2 (Dose Number: 2, Batch/Lot No: EN6201, Location of injection: Arm Left), administration date: 11Feb2021, when the patient was 32-year-old, for COVID-19 immunization.  The following information was reported: CHEST PAIN (hospitalization, disability, life threatening), PULMONARY PAIN (hospitalization, disability, life threatening) all with onset 17Oct2021, outcome "recovered with sequelae" and all described as "Abnormal pains in chest from lungs"; MUSCULOSKELETAL CHEST PAIN (hospitalization, disability, life threatening) with onset 17Oct2021, outcome "recovered with sequelae", described as "Pain in xyphoid process area"; LYMPH NODE CALCIFICATION (hospitalization, disability, life threatening), LYMPH GLAND INFECTION (hospitalization, disability, life threatening), LYMPHADENOPATHY (hospitalization, disability, life threatening), PAIN (hospitalization, disability, life threatening) all with onset 17Oct2021, outcome "recovered with sequelae" and all described as "Significant amount of lymph nodes calcified with one becoming infected and enlarged near my heart and still causing pain and discomfort"; DISCOMFORT (hospitalization, disability, life threatening) with onset 17Oct2021, outcome "recovered with sequelae", described as "Significant amount of lymph nodes calcified with one becoming infected and enlarged near my heart and still causing pain and discomfort / discomfort in xyphoid process area"; FATIGUE (hospitalization, disability, life threatening), BLOOD TESTOSTERONE ABNORMAL (hospitalization, disability, life threatening) all with onset 17Oct2021, outcome "recovered with sequelae" and all described as "Significantly and frequently exhausted with testosterone loss". The patient was hospitalized for lymph node calcification, lymph gland infection, lymphadenopathy, pain, discomfort, chest pain, pulmonary pain, musculoskeletal chest pain, fatigue, blood testosterone abnormal (hospitalization duration: 20 day(s)). The events "significant amount of lymph nodes calcified with one becoming infected and enlarged near my heart and still causing pain and discomfort", "significant amount of lymph nodes calcified with one becoming infected and enlarged near my heart and still causing pain and discomfort / discomfort in xyphoid process area", "abnormal pains in chest from lungs", "pain in xyphoid process area" and "significantly and frequently exhausted with testosterone loss" required physician office visit and emergency room visit.  The patient was hospitalized for lymph node calcification, lymph gland infection, lymphadenopathy, pain, discomfort, chest pain, musculoskeletal chest pain, fatigue, blood testosterone abnormal (hospitalization duration: 20 day(s)). The events "significant amount of lymph nodes calcified with one becoming infected and enlarged near my heart and still causing pain and discomfort", "significant amount of lymph nodes calcified with one becoming infected and enlarged near my heart and still causing pain and discomfort / discomfort in xyphoid process area", "abnormal pains in chest from lungs", "pain in xyphoid process area" and "significantly and frequently exhausted with testosterone loss" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Blood testosterone: (17Oct2021) loss. Therapeutic measures were taken as a result of lymph node calcification, lymph gland infection, lymphadenopathy, pain, discomfort, chest pain, musculoskeletal chest pain, fatigue, blood testosterone abnormal which included antibiotic treatment for over one year.